| Bioactivity | CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73). CD73-IN-18 can be used in anti-cancer research[1]. |
| CAS | 3037968-61-6 |
| Formula | C20H17N5O3 |
| Molar Mass | 375.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xu Y, et al. Discovery of Novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase. J Med Chem. 2024 Oct 10. |
CD73-IN-18
CAS: 3037968-61-6 F: C20H17N5O3 W: 375.38
CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73). CD73-IN-18 can be use
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.